Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
fdmt
/
4D Molecular Therapeutics Inc
FDMT
Add to Watchlist
10.180
USD
+0.110
+1.09%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/03, 09:30 (ET)
532.17M
Market Cap
Loss
P/E TTM
4D Molecular Therapeutics Inc
10.180
+0.110
+1.09%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
10.81%
Janus Henderson Investors
10.04%
BVF Partners L.P.
8.86%
Goldman Sachs & Company, Inc.
7.39%
Novo Holdings A/S
6.98%
Other
55.92%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
10.81%
Janus Henderson Investors
10.04%
BVF Partners L.P.
8.86%
Goldman Sachs & Company, Inc.
7.39%
Novo Holdings A/S
6.98%
Other
55.92%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
30.15%
Hedge Fund
24.64%
Venture Capital
18.14%
Investment Advisor
14.37%
Research Firm
11.48%
Individual Investor
3.55%
Bank and Trust
0.17%
Pension Fund
0.08%
Insurance Company
0.03%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
363
54.90M
105.02%
-3.49M
2025Q4
341
40.63M
123.08%
--
2025Q3
346
40.63M
123.81%
+1.46K
2025Q2
352
40.62M
126.04%
-3.84M
2025Q1
351
44.47M
124.74%
-13.29M
2024Q4
351
47.77M
132.92%
-5.15M
2024Q3
343
58.58M
121.63%
+168.00K
2024Q2
333
58.21M
117.71%
+835.97K
2024Q1
317
57.48M
92.47%
+10.17M
2023Q4
276
43.57M
106.83%
+555.36K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
5.65M
11.07%
+1.09M
+23.89%
Dec 31, 2025
Janus Henderson Investors
4.64M
9.08%
+2.88M
+164.40%
Dec 31, 2025
BVF Partners L.P.
4.63M
9.07%
--
--
Dec 31, 2025
Goldman Sachs & Company, Inc.
3.86M
7.56%
+153.54K
+4.14%
Dec 31, 2025
Novo Holdings A/S
3.65M
7.15%
+475.74K
+14.98%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.29M
6.44%
+279.13K
+9.28%
Dec 31, 2025
State Street Investment Management (US)
2.69M
5.27%
+1.79M
+197.52%
Dec 31, 2025
Armistice Capital LLC
1.94M
3.79%
+840.00K
+76.64%
Dec 31, 2025
Kirn (David)
1.66M
3.25%
-360.00
-0.02%
Apr 24, 2025
Point72 Asset Management, L.P.
1.54M
3.02%
+1.54M
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Federated Hermes MDT Small Cap Core ETF
0.43%
Harbor Human Capital Factor US Small Cap ETF
0.1%
iShares Micro-Cap ETF
0.09%
iShares Health Innovation Active ETF
0.08%
ProShares Ultra Nasdaq Biotechnology
0.07%
Invesco Nasdaq Biotechnology ETF
0.05%
iShares Biotechnology ETF
0.04%
Avantis US Small Cap Equity ETF
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Value ETF
0.03%
View more
Federated Hermes MDT Small Cap Core ETF
Proportion
0.43%
Harbor Human Capital Factor US Small Cap ETF
Proportion
0.1%
iShares Micro-Cap ETF
Proportion
0.09%
iShares Health Innovation Active ETF
Proportion
0.08%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.07%
Invesco Nasdaq Biotechnology ETF
Proportion
0.05%
iShares Biotechnology ETF
Proportion
0.04%
Avantis US Small Cap Equity ETF
Proportion
0.04%
Invesco RAFI US 1500 Small-Mid ETF
Proportion
0.03%
iShares Russell 2000 Value ETF
Proportion
0.03%